With $1.1 billion allocated to comparative effectiveness research in the new stimulus package, the concept has suddenly gone from a wonkish concern to a topic of conversation among health advocates everywhere. The question, observers say, is whether a given interest group will be able to frame the research program to suit their agenda. Article